Company / Free Cash Flow per Share
ImmunityBio, Inc. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.36
FY2025
5-year range
-$1.04 / -$0.36
FY2021-FY2025
Trend
+39.0%
vs FY2024
Sector context
#81 of 192
Health Care
What the data says
At $-0.36, ImmunityBio, Inc.'s free cash flow per share ranks #81 of 192 in the Health Care sector. Free Cash Flow per Share has increased for 3 consecutive years, from $-1.04 in FY2022 to $-0.36 in FY2025.
Based on SEC 10-K filings.
-0.36 in FY2025.
Improved from $-0.94 to $-0.36 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#81 of 192 in Health CareTop 42% of 192This company -$0.36 Sector average $3.32
▼
-110.9% below sector average
Key checks
Key Insights
- ImmunityBio, Inc.'s free cash flow per share has grown for 3 consecutive years.
- In FY2025, free cash flow per share increased 39.0% year-over-year.
- Ranks #81 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -7.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.36 | +39.0% |
| FY2024 | -$0.59 | +37.0% |
| FY2023 | -$0.94 | +9.8% |
| FY2022 | -$1.04 | -155.4% |
| FY2021 | -$0.41 | +76.8% |
| FY2020 | -$1.76 | +10.9% |
| FY2019 | -$1.98 | -246.1% |
| FY2018 | -$0.57 | -70.1% |
| FY2017 | -$0.34 | -383.3% |
| FY2016 | -$0.07 | +99.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026